Weekly Newsletter

Dafinchi Weekly Newsletter

The earnings shifts, investor discussions, and market signals worth knowing—summarized in one concise email.

Email address

Delivered every week. Unsubscribe anytime.

Latest Earnings

Dafinchi

Highlights Feed Latest Earnings Newsletter Blog Company Finder

Dafinchi

Newsletternew My Portfolio Highlights Feed Latest Earnings Annual Reviews Earnings Chat Earnings Coach Keyword Scan Deep Research Company Finder Blog Guides Compare Earnings Shareholder Letter History

Quick Links

MCP — Connect your AI About Us FAQs Contact Us Privacy Policy Cookies Policy Terms and Condition Acceptable Use Policy Data Processing Addendum

Filana Therapeutics, Inc. (FLNA) Company Profile - Dafinchi AI

Filana Therapeutics, Inc. (FLNA) Company Profile

Healthcare

Biotechnology

Company Overview

Detailed company information

Basic Information

Ticker: FLNA

Country: US

Headquarter: Austin, TX

Employees: 19

Financial Information

Market Cap: $43.4 Million

Currency: USD

Sector: Healthcare

Industry: Biotechnology

Stock Price Chart

Stock Data provided by Financial Modeling Prep

About Filana Therapeutics, Inc.

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.

Last Updated: Sep 2026